COSCIENS Biopharma Inc. Increase Decrease Through Net Exchange Differences Goodwill
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease Through Net Exchange Differences Goodwill of -$488.00 thousand for the 12-month period ending 2022-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesGoodwill · last filed 2024-07-17
- COSCIENS Biopharma Inc. increase decrease through net exchange differences goodwill for the quarter ending 2020-12-31 was $409.00K.
- COSCIENS Biopharma Inc. increase decrease through net exchange differences goodwill for the quarter ending 2020-09-30 was $352.00K.
- COSCIENS Biopharma Inc. increase decrease through net exchange differences goodwill for the quarter ending 2020-06-30 was $172.00K.
- COSCIENS Biopharma Inc. increase decrease through net exchange differences goodwill for the quarter ending 2020-03-31 was -$168.00K.
| Period end | Increase Decrease Through Net Exchange Differences Goodwill 3 month | Increase Decrease Through Net Exchange Differences Goodwill 6 month | Increase Decrease Through Net Exchange Differences Goodwill 9 month | Increase Decrease Through Net Exchange Differences Goodwill 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$488.00K 20-F/A · filed 2024-07-17 | |||
| 2021-12-31 | -$685.00K 20-F/A · filed 2024-02-15 | |||
| 2020-12-31 | $409.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | $761.00K derived: sum of 2 quarters · filed 2022-03-29 | $933.00K derived: sum of 3 quarters · filed 2022-03-29 | $765.00K 20-F · filed 2022-03-29 |
| 2020-09-30 | $352.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-11-05 | $524.00K derived: sum of 2 quarters · filed 2020-11-05 | $356.00K 6-K · filed 2020-11-05 | |
| 2020-06-30 | $172.00K derived: 6-K 6 month − 6-K/A 3 month · filed 2020-08-06 | $4.00K 6-K · filed 2020-08-06 | ||
| 2020-03-31 | -$168.00K 6-K/A · filed 2020-05-11 | |||
| 2019-12-31 | -$160.00K 40-F/A · filed 2021-03-29 | |||
| 2018-12-31 | -$403.00K 20-F · filed 2020-03-31 |